21 results on '"Sezer O"'
Search Results
2. Selected Abstract Zoledronic acid therapy versus control in patients with Multiple Myeloma in stage I (Durie & Salmon): Results of a phase III study of the “Deutsche Studiengruppe Multiples Myelom (DSMM)” and “Ostdeutsche Studiengruppe Haematologie und Onkologie (OSHO)”: V347
3. Bortezomib, iv cyclophosphamide and dexamethasone (VCD) as induction therapy in newly diagnosed multiple myeloma: Update on the interim results with 300 patients of the German DSMM XIa trial: V333 - Best Abstract
4. Gemcitabine as Prolonged Infusion and Vinorelbine as Second-Line Therapy in Metastatic Breast Cancer: A Phase-II Study: O384
5. Comparison of Two High-Dose Chemotherapy Regimens and Autologous Stem Cell Transplantation in Patients with De Novo Multiple Myeloma: O181
6. Serum Proteasome Levels are Increased in Patients with Multiple Myeloma and Decrease after Response to Chemotherapy: O176
7. Treatment of refractory chronic lymphocytic leukemia with alemtuzumab (Campath) in chronic hepatitis B infection: P864
8. Expression of “receptor activator of NF-kappa B ligand” (RANKL) mRNA in human multiple myeloma cells: P691
9. Expression of high-mobility-group-protein HMGI-C mRNA in the peripheral blood is a prognostic indicator for poor survival in patients with lung cancer: V309
10. Prognostic value of circulating levels of angiogenic cytokines vascular endothelial growth factor, fibroblast growth factor and hepatocyte growth factor in patients with multiple myeloma: V310
11. Firstline therapy in patients with advanced chronic lymphocytic leukemia with fludarabine versus fludarabine plus cyclophosphamide: Interim analysis of a cooperative phase III study of the German CLL Study Group (GCLLSG): V183
12. Expression of high-mobility-group-protein HMGI-C mRNA in the peripheral blood is an independent poor prognostic indicator for survival in metastatic breast cancer: 939
13. ICTP serum levels can be used as a surrogate marker for skeletal involvement in multiple myeloma patients lacking osteolytic lesions in conventional radiography: 754
14. Biweekly Pegylated Liposomal Doxorubicin (Caelyx/Doxil) in heavily pretreated metastatic breast cancer: 743
15. Analysis of 2 clinical trials with contradictory results in advanced breast cancer: 744
16. Development of an EORTC questionnaire module for assessment of quality of life during high-dose chemotherapy and haematopoietic stem cell transplantation: 356
17. A comparison of the clinical applicability of three collagen I degradation products for the evaluation of myeloma-induced bone disease: 260
18. Expression of receptor activator of NF-kappa B ligand (RANKL) by human myeloma cells: 246
19. Prolonged infusion of gemcitabine in advanced solid tumors: A phase-I-study: 182
20. Use of Bisphosphonates in Therapy and Prophylaxis of Cancer-Induced Bone Diseases
21. Palliative Chemotherapy in Advanced Non-Small-Cell Lung Cancer: Goals and Reality
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.